WEBULL
News
RDHL
1.070
+3.88%
0.040
Weekly Report: what happened at RDHL last week (0202-0206)?
Weekly Report · 2h ago
Weekly Report: what happened at RDHL last week (0126-0130)?
Weekly Report · 02/02 10:07
RedHill Biopharma Calls March 5 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
TipRanks · 01/27 12:27
Weekly Report: what happened at RDHL last week (0119-0123)?
Weekly Report · 01/26 10:06
RedHill Biopharma Calls March 5, 2026 Extraordinary Meeting to Approve RSU Grants and Share Capital Increase
TipRanks · 01/22 14:17
Weekly Report: what happened at RDHL last week (0112-0116)?
Weekly Report · 01/19 10:12
Weekly Report: what happened at RDHL last week (0105-0109)?
Weekly Report · 01/12 10:11
What's Going On With Redhill Biopharma Stock On Tuesday?
Benzinga · 01/06 15:26
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/06 12:05
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Benzinga · 01/06 09:45
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 01/05 17:05
Market-Moving News for January 5th
Benzinga · 01/05 12:44
RedHill Biopharma Advances RHB-102 in GI Indications and GLP-1 Therapy Support
TipRanks · 01/05 12:27
RedHill Expands RHB-102 Clinical Development Addressing GLP-1 Therapy-Related GI Side Effects And Broader GI Indications
Benzinga · 01/05 12:15
RedHill Biopharma announces development progress for RHB-102
TipRanks · 01/05 12:05
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
PR Newswire · 01/05 12:00
Weekly Report: what happened at RDHL last week (1229-0102)?
Weekly Report · 01/05 10:06
RedHill Biopharma Files Pro Forma Financials After Talicia Joint Venture Deal With Cumberland
TipRanks · 12/31/2025 22:17
Weekly Report: what happened at RDHL last week (1222-1226)?
Weekly Report · 12/29/2025 10:05
Redhill Biopharma Granted U.S. Patent #12,502,381 Titled "SERINE PROTEASE INHIBITOR FOR TREATING CORONAVIRUS INFECTION"
Benzinga · 12/23/2025 18:06
More
Webull provides a variety of real-time RDHL stock news. You can receive the latest news about Redhill Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.